EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access

Extension and Further Replication of the Reliability, Criterion Validity, and Treatment Sensitivity of the PANSS10 and PANSS20 for Pediatric Trials

Joshua A Langfus iD, Eric A Youngstrom, David Daniel, Joan Busner, Robert L Findling

Journal of Child and Adolescent Psychopharmacology · 2024-12 · 34 (10) · 447-457

DOI: 10.1089/cap.2024.0078 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Journal of Child and Adolescent Psychopharmacology, online erschienen am 02.12.2024. Verfasst von Joshua A Langfus und 4 weiteren Autor:innen. Beteiligte Einrichtung: University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA. Hauptthemen laut MEDLINE: Aripiprazole, Psychometrics, Antipsychotic Agents, Psychiatric Status Rating Scales. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

The Positive and Negative Syndrome Scale (PANSS) is a widely accepted outcome measure for pediatric schizophrenia trials; however, it has notable limitations. Psychometric investigations have shown a multifactorial structure and some items have limited utility assessing symptom severity in children. To address these issues, we developed and evaluated optimized 10- and 20-item PANSS short-forms (PANSS10 and PANSS20) using patient-level clinical trial data. This study further assesses these optimized forms using independent clinical trial data.

Methods

We examined patient-level data from a randomized pediatric schizophrenia trial comparing paliperidone ER to aripiprazole. Data were accessed through the Yale Open Data Access (YODA) secure platform. Analyses included confirmatory factor analyses, graded response models, ω score reliability, internal consistency, sensitivity to change, and criterion validity versus the Clinical Global Impressions of Severity (CGI-S). Bland–Altman analyses examined score calibration versus the 30-item PANSS and inclusion cut scores.

Results

Participants ( N = 288) were ages 12 to 17 years ( M = 15.3, SD = 1.46; 66% male). Total scores for the PANSS10 and PANSS20 showed strong correlations with the 30-item PANSS (0.90 and 0.97, respectively). Average inter-item correlations were 0.10 and 0.14 and ω Total reliabilities were 0.74 and 0.85. Both PANSS10 and PANSS20 scores showed reliability >0.80–2.3 to 4.5 SD and −3.0 to 6.0 SD about mean symptom severity, respectively. Sensitivity to treatment was also similar (partial eta squared 0.23 and 0.22), as was correlation with CGI-S at baseline (0.45 and 0.48; not significantly different). The mean item-average discrepancy with the 30-item PANSS was 0.095 for PANSS10 and 0.033 for PANSS20.

Conclusions

The optimized PANSS forms continue to show impressive reliability, validity, and calibration compared with the 30-item PANSS. Researchers should consider replacing the 30-item PANSS with the PANSS10 as a clinical outcome and screening measure due to its length and psychometric performance.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AripiprazolePsychometricsAntipsychotic AgentsPsychiatric Status Rating ScalesSchizophreniaHumansChildMaleReproducibility of ResultsAdolescentFemalePaliperidone PalmitateSeverity of Illness Index

Stichwörter der Autor:innen

PANSSassessmentpediatric trialsschizophrenia

Substanzen

AripiprazoleAntipsychotic AgentsPaliperidone Palmitate

Autor:innen und Institutionen

  • University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
  • Nationwide Children's Hospital and The Ohio State University, Columbus, Ohio, USA.
  • Helping Give Away Psychological Science, Chapel Hill, North Carolina, USA.
  • Signant Health, Wayne, Pennsylvania, USA.
  • George Washington University, Washington, DC, USA.
  • Virginia Commonwealth University, Richmond, VA, USA.

ORCID-Profile: Joshua A Langfus

Zitieren

APA

Langfus, J. A., Youngstrom, E. A., Daniel, D., Busner, J., & Findling, R. L. (2024). Extension and Further Replication of the Reliability, Criterion Validity, and Treatment Sensitivity of the PANSS10 and PANSS20 for Pediatric Trials. Journal of Child and Adolescent Psychopharmacology, 34(10), 447-457. https://doi.org/10.1089/cap.2024.0078

Vancouver

Langfus JA, Youngstrom EA, Daniel D, Busner J, Findling RL. Extension and Further Replication of the Reliability, Criterion Validity, and Treatment Sensitivity of the PANSS10 and PANSS20 for Pediatric Trials. Journal of Child and Adolescent Psychopharmacology. 2024;34(10):447-457. doi:10.1089/cap.2024.0078

BibTeX
@article{Langfus2024,
  author = {Langfus, Joshua A and Youngstrom, Eric A and Daniel, David and Busner, Joan and Findling, Robert L},
  title = {Extension and Further Replication of the Reliability, Criterion Validity, and Treatment Sensitivity of the PANSS10 and PANSS20 for Pediatric Trials},
  journal = {Journal of Child and Adolescent Psychopharmacology},
  year = {2024},
  volume = {34},
  number = {10},
  pages = {447--457},
  doi = {10.1089/cap.2024.0078}
}
Kostenlos starten →